Evidence map›Paper›PMID 34320337›Full record

ArticleCell reports2021

Molecular control of cell density-mediated exit to quiescence.

Yilin Fan, Tobias Meyer

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 65 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Linking tissue morphology and tissue healing in a cell-fate model.Frontiers in cell and developmental biology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Targeting CDK4/6 in breast cancer.Experimental & molecular medicine · 2025
    Review
  13. Review
  14. Capturing the mechanosensitivity of cell proliferation in models of epithelium.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Yilin FanDepartment of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Cell and Developmental Biology, Weill Cornell Medicine, New York, NY 10065, USA.
Tobias MeyerDepartment of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Cell and Developmental Biology, Weill Cornell Medicine, New York, NY 10065, USA. Electronic address: tobias1@stanford.edu.
Cornell University · USStanford University · US

Funding

Cell Signaling and Cell DecisionsR35GM127026 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI TOBIAS MEYER · 2018 to 2026
$8.5M
NIGMS NIH HHS R35 GM127026
6 · The paper itself

Abstract

Contact inhibition of cell proliferation regulates tissue size and prevents uncontrolled cell expansion. When cell density increases, contact inhibition can force proliferating cells into quiescence. Here we show that the variable memory of local cell density experienced by a mother cell controls the levels of the cyclin-dependent kinase (CDK) activator cyclin D1 and inhibitor p27 in newborn daughters, which direct cells to proliferation or quiescence. Much of this regulation can be explained by rapid suppression of ERK activity by high cell density in mothers, which leads to lower cyclin D1 and higher p27 levels in daughters. Strikingly, cell density and mitogen signals compete by shifting the ratio of cyclin D1/p27 levels below or above a single sharp threshold that controls the proliferation decision. Thus, the history of competing cell density and mitogen signals experienced by mothers is funneled into a precise activator-inhibitor balance that decides the fate of daughter cells.

Indexed as

Cell CountCell CycleCyclin D1Cyclin-Dependent Kinase Inhibitor p27FemaleHumansMAP Kinase Signaling SystemMitogen-Activated Protein Kinase KinasesMitogensModels, BiologicalPhosphorylationRetinoblastoma ProteinCyclin D1Cyclin-Dependent Kinase Inhibitor p27Mitogen-Activated Protein Kinase KinasesMitogensRetinoblastoma ProteinCDKcell cyclecell densitycell proliferationcontact inhibitionERKquiescenceultrasensitivity

Identifiers

PMID34320337
PMCPMC8924979
OpenAlexW3185598526

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.